Cell therapy weekly: Is stem cell transplant survival associated with procedure performance number?
The week: RMAT designation for Wiskott-Aldrich Syndrome therapy, EQT (NY, USA) to attain majority stake in Aldevron (ND, USA) and genetic modification of blood stem cells reverses blood disorder phenotypes.
Please sign in or register for FREE
Sign in to RegMedNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Regenerative Medicine FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RegMedNet account also gives you access to communities on drug discovery, real-world evidence and 3D printing in medicine. Find out more>>